Daraxonrasib
trans-(1S,2S)-N-[(7S,13S)-21-ethyl-20-[2-[(1S)-1-methoxyethyl]-5-(4-methylpiperazin-1-yl)-3-pyridinyl]-17,17-dimethyl-8,14-dioxo-15-oxa-4-thia-9,21,27,28-tetrazapentacyclo[17.5.2.12,5.19,13.022,26]octacosa-1(25),2,5(28),19,22(26),23-hexaen-7-yl]-2-methylcyclopropane-1-carboxamide
Molecular Identity
Daraxonrasib
trans-(1S,2S)-N-[(7S,13S)-21-ethyl-20-[2-[(1S)-1-methoxyethyl]-5-(4-methylpiperazin-1-yl)-3-pyridinyl]-17,17-dimethyl-8,14-dioxo-15-oxa-4-thia-9,21,27,28-tetrazapentacyclo[17.5.2.12,5.19,13.022,26]octacosa-1(25),2,5(28),19,22(26),23-hexaen-7-yl]-2-methylcyclopropane-1-carboxamide
PubChem CID: 164726578
2D Structure
Properties
C44H58N8O5S
Molecular Formula
811.00
Molecular Weight
g/mol
810.4251
Exact Mass
Da
5.1
XLogP
Above Lipinski threshold
162
TPSA
May have limited oral absorption
2
H-Bond Donors
11
H-Bond Acceptors
1470
Complexity
SMILES
Canonical SMILES
SMILES: Synonyms(20)
Daraxonrasib2765081-21-6B6T47Y2UAPRefChem:1082975RAS-IN-2RMC-6236RAS Inhibitor A122RMC6236A1AHBdaraxonrasib [INN]SCHEMBL25774297SCHEMBL31152365EX-A6631BGTPL13368GLXC-27997
Data from PubChem (NCBI)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Drug Network
Trials and conditions connected to Daraxonrasib
Loading drug network...